nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A5—Dactinomycin—sarcoma	0.228	0.48	CbGbCtD
Procainamide—SLC22A3—Vincristine—sarcoma	0.226	0.476	CbGbCtD
Procainamide—CYP2D6—Doxorubicin—sarcoma	0.021	0.0442	CbGbCtD
Procainamide—BCHE—diaphragm—sarcoma	0.0122	0.0788	CbGeAlD
Procainamide—SLC22A4—larynx—sarcoma	0.01	0.0646	CbGeAlD
Procainamide—DNMT1—Vinblastine—Vincristine—sarcoma	0.00738	1	CbGdCrCtD
Procainamide—DNMT1—mammary gland—sarcoma	0.00525	0.0338	CbGeAlD
Procainamide—SCN7A—myometrium—sarcoma	0.00485	0.0312	CbGeAlD
Procainamide—Sunitinib—FLT1—sarcoma	0.00396	0.227	CrCbGaD
Procainamide—Hepatomegaly—Thiotepa—sarcoma	0.00374	0.0203	CcSEcCtD
Procainamide—DNMT1—myometrium—sarcoma	0.00372	0.024	CbGeAlD
Procainamide—Hepatomegaly—Dactinomycin—sarcoma	0.00372	0.0201	CcSEcCtD
Procainamide—DNMT1—embryo—sarcoma	0.00358	0.0231	CbGeAlD
Procainamide—DNMT1—seminal vesicle—sarcoma	0.00336	0.0217	CbGeAlD
Procainamide—Sunitinib—PDGFRB—sarcoma	0.00328	0.188	CrCbGaD
Procainamide—SLC22A4—mammary gland—sarcoma	0.00325	0.0209	CbGeAlD
Procainamide—DNMT1—hematopoietic system—sarcoma	0.0032	0.0206	CbGeAlD
Procainamide—Sunitinib—PDGFRA—sarcoma	0.0032	0.183	CrCbGaD
Procainamide—SCN7A—cardiac atrium—sarcoma	0.00316	0.0204	CbGeAlD
Procainamide—DNMT1—connective tissue—sarcoma	0.00308	0.0198	CbGeAlD
Procainamide—Oliguria—Thiotepa—sarcoma	0.00288	0.0156	CcSEcCtD
Procainamide—DNMT1—skin of body—sarcoma	0.00278	0.0179	CbGeAlD
Procainamide—SCN2A—hematopoietic system—sarcoma	0.00257	0.0166	CbGeAlD
Procainamide—Sunitinib—KDR—sarcoma	0.00249	0.142	CrCbGaD
Procainamide—SCN10A—hematopoietic system—sarcoma	0.00248	0.016	CbGeAlD
Procainamide—Pericarditis—Epirubicin—sarcoma	0.00247	0.0134	CcSEcCtD
Procainamide—DNMT1—cardiac atrium—sarcoma	0.00243	0.0156	CbGeAlD
Procainamide—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00242	0.0131	CcSEcCtD
Procainamide—DNMT1—uterus—sarcoma	0.00241	0.0156	CbGeAlD
Procainamide—Sunitinib—KIT—sarcoma	0.00235	0.134	CrCbGaD
Procainamide—SLC22A4—myometrium—sarcoma	0.00231	0.0149	CbGeAlD
Procainamide—Pericarditis—Doxorubicin—sarcoma	0.00228	0.0124	CcSEcCtD
Procainamide—SCN7A—testis—sarcoma	0.00228	0.0147	CbGeAlD
Procainamide—DNMT1—lymphoid tissue—sarcoma	0.00225	0.0145	CbGeAlD
Procainamide—Lidocaine—EGFR—sarcoma	0.00217	0.125	CrCbGaD
Procainamide—SCN9A—tendon—sarcoma	0.00216	0.0139	CbGeAlD
Procainamide—SCN7A—liver—sarcoma	0.00216	0.0139	CbGeAlD
Procainamide—SLC22A5—mammary gland—sarcoma	0.00215	0.0139	CbGeAlD
Procainamide—Hepatic failure—Thiotepa—sarcoma	0.00214	0.0116	CcSEcCtD
Procainamide—Hepatic failure—Dactinomycin—sarcoma	0.00212	0.0115	CcSEcCtD
Procainamide—DNMT1—tendon—sarcoma	0.00212	0.0136	CbGeAlD
Procainamide—SLC22A3—myometrium—sarcoma	0.0021	0.0135	CbGeAlD
Procainamide—SLC22A4—seminal vesicle—sarcoma	0.00208	0.0134	CbGeAlD
Procainamide—DNMT1—bone marrow—sarcoma	0.00205	0.0132	CbGeAlD
Procainamide—SCN8A—testis—sarcoma	0.00203	0.0131	CbGeAlD
Procainamide—SLC22A3—embryo—sarcoma	0.00202	0.013	CbGeAlD
Procainamide—Cardiac failure—Thiotepa—sarcoma	0.00197	0.0107	CcSEcCtD
Procainamide—Lethargy—Dactinomycin—sarcoma	0.00195	0.0105	CcSEcCtD
Procainamide—SCN4A—tendon—sarcoma	0.00192	0.0124	CbGeAlD
Procainamide—Hepatic failure—Vincristine—sarcoma	0.0019	0.0103	CcSEcCtD
Procainamide—SLC22A3—seminal vesicle—sarcoma	0.0019	0.0122	CbGeAlD
Procainamide—Cardiac arrest—Thiotepa—sarcoma	0.00183	0.0099	CcSEcCtD
Procainamide—SLC22A3—hematopoietic system—sarcoma	0.0018	0.0116	CbGeAlD
Procainamide—SCN9A—testis—sarcoma	0.00179	0.0115	CbGeAlD
Procainamide—DNMT1—testis—sarcoma	0.00175	0.0113	CbGeAlD
Procainamide—SCN10A—lymphoid tissue—sarcoma	0.00175	0.0113	CbGeAlD
Procainamide—SLC22A3—connective tissue—sarcoma	0.00174	0.0112	CbGeAlD
Procainamide—Rash maculo-papular—Etoposide—sarcoma	0.00173	0.00937	CcSEcCtD
Procainamide—ACHE—tendon—sarcoma	0.00172	0.0111	CbGeAlD
Procainamide—SCN5A—cardiac atrium—sarcoma	0.00171	0.011	CbGeAlD
Procainamide—Cardiac failure—Mitoxantrone—sarcoma	0.0017	0.00922	CcSEcCtD
Procainamide—DNMT1—liver—sarcoma	0.00166	0.0107	CbGeAlD
Procainamide—SCN7A—lymph node—sarcoma	0.00165	0.0106	CbGeAlD
Procainamide—Cardiac arrest—Vincristine—sarcoma	0.00162	0.00878	CcSEcCtD
Procainamide—SCN4A—testis—sarcoma	0.00159	0.0103	CbGeAlD
Procainamide—SLC22A3—smooth muscle tissue—sarcoma	0.00159	0.0102	CbGeAlD
Procainamide—Neutropenia—Dactinomycin—sarcoma	0.00154	0.00835	CcSEcCtD
Procainamide—SLC22A5—myometrium—sarcoma	0.00153	0.00983	CbGeAlD
Procainamide—Abdominal pain upper—Mitoxantrone—sarcoma	0.00152	0.00822	CcSEcCtD
Procainamide—Hepatomegaly—Epirubicin—sarcoma	0.00151	0.00816	CcSEcCtD
Procainamide—SCN3A—tendon—sarcoma	0.0015	0.00964	CbGeAlD
Procainamide—BCHE—myometrium—sarcoma	0.00149	0.00957	CbGeAlD
Procainamide—Renal failure—Thiotepa—sarcoma	0.00146	0.00789	CcSEcCtD
Procainamide—SCN3A—bone marrow—sarcoma	0.00145	0.00934	CbGeAlD
Procainamide—ACHE—testis—sarcoma	0.00142	0.00917	CbGeAlD
Procainamide—Cardiac failure—Etoposide—sarcoma	0.00142	0.00767	CcSEcCtD
Procainamide—Hepatomegaly—Doxorubicin—sarcoma	0.0014	0.00755	CcSEcCtD
Procainamide—Pleural effusion—Epirubicin—sarcoma	0.00139	0.00754	CcSEcCtD
Procainamide—Agranulocytosis—Thiotepa—sarcoma	0.00138	0.00749	CcSEcCtD
Procainamide—Neutropenia—Vincristine—sarcoma	0.00138	0.00746	CcSEcCtD
Procainamide—SLC22A5—seminal vesicle—sarcoma	0.00138	0.00888	CbGeAlD
Procainamide—Agranulocytosis—Dactinomycin—sarcoma	0.00137	0.00743	CcSEcCtD
Procainamide—BCHE—seminal vesicle—sarcoma	0.00134	0.00865	CbGeAlD
Procainamide—Neutropenia—Mitoxantrone—sarcoma	0.00134	0.00727	CcSEcCtD
Procainamide—Hallucination—Thiotepa—sarcoma	0.00132	0.00717	CcSEcCtD
Procainamide—Cardiac arrest—Etoposide—sarcoma	0.00131	0.00711	CcSEcCtD
Procainamide—Depression—Vincristine—sarcoma	0.00131	0.0071	CcSEcCtD
Procainamide—SLC22A4—tendon—sarcoma	0.00131	0.00844	CbGeAlD
Procainamide—SCN9A—lymph node—sarcoma	0.00129	0.00834	CbGeAlD
Procainamide—Pleural effusion—Doxorubicin—sarcoma	0.00129	0.00698	CcSEcCtD
Procainamide—BCHE—hematopoietic system—sarcoma	0.00128	0.00822	CbGeAlD
Procainamide—DNMT1—lymph node—sarcoma	0.00127	0.00818	CbGeAlD
Procainamide—SLC22A4—bone marrow—sarcoma	0.00127	0.00818	CbGeAlD
Procainamide—Renal failure—Mitoxantrone—sarcoma	0.00126	0.00681	CcSEcCtD
Procainamide—SCN3A—testis—sarcoma	0.00124	0.00798	CbGeAlD
Procainamide—Cardiac disorder—Thiotepa—sarcoma	0.00124	0.00669	CcSEcCtD
Procainamide—Flushing—Dactinomycin—sarcoma	0.00123	0.00664	CcSEcCtD
Procainamide—Agranulocytosis—Mitoxantrone—sarcoma	0.00119	0.00647	CcSEcCtD
Procainamide—Chills—Thiotepa—sarcoma	0.00119	0.00647	CcSEcCtD
Procainamide—Chills—Dactinomycin—sarcoma	0.00119	0.00642	CcSEcCtD
Procainamide—Hallucination—Vincristine—sarcoma	0.00117	0.00636	CcSEcCtD
Procainamide—Bradycardia—Mitoxantrone—sarcoma	0.00117	0.00633	CcSEcCtD
Procainamide—Oliguria—Epirubicin—sarcoma	0.00116	0.00627	CcSEcCtD
Procainamide—SLC22A5—skin of body—sarcoma	0.00114	0.00734	CbGeAlD
Procainamide—BCHE—smooth muscle tissue—sarcoma	0.00112	0.00724	CbGeAlD
Procainamide—Neutropenia—Etoposide—sarcoma	0.00112	0.00605	CcSEcCtD
Procainamide—BCHE—skin of body—sarcoma	0.00111	0.00715	CbGeAlD
Procainamide—Cardiac disorder—Vincristine—sarcoma	0.0011	0.00593	CcSEcCtD
Procainamide—Oliguria—Doxorubicin—sarcoma	0.00107	0.0058	CcSEcCtD
Procainamide—Ventricular tachycardia—Epirubicin—sarcoma	0.00107	0.00578	CcSEcCtD
Procainamide—Ill-defined disorder—Dactinomycin—sarcoma	0.00107	0.00578	CcSEcCtD
Procainamide—Renal failure—Etoposide—sarcoma	0.00105	0.00567	CcSEcCtD
Procainamide—Malaise—Dactinomycin—sarcoma	0.00104	0.00561	CcSEcCtD
Procainamide—ACHE—lymph node—sarcoma	0.00103	0.00664	CbGeAlD
Procainamide—Chills—Mitoxantrone—sarcoma	0.00103	0.00558	CcSEcCtD
Procainamide—Convulsion—Thiotepa—sarcoma	0.001	0.00543	CcSEcCtD
Procainamide—SLC22A5—cardiac atrium—sarcoma	0.000995	0.00641	CbGeAlD
Procainamide—Agranulocytosis—Etoposide—sarcoma	0.000994	0.00538	CcSEcCtD
Procainamide—SLC22A3—testis—sarcoma	0.000988	0.00636	CbGeAlD
Procainamide—Ventricular tachycardia—Doxorubicin—sarcoma	0.000988	0.00535	CcSEcCtD
Procainamide—Arthralgia—Thiotepa—sarcoma	0.000987	0.00534	CcSEcCtD
Procainamide—Myalgia—Thiotepa—sarcoma	0.000987	0.00534	CcSEcCtD
Procainamide—SCN10A—lymph node—sarcoma	0.000986	0.00635	CbGeAlD
Procainamide—Dysgeusia—Mitoxantrone—sarcoma	0.00098	0.0053	CcSEcCtD
Procainamide—Myalgia—Dactinomycin—sarcoma	0.000979	0.0053	CcSEcCtD
Procainamide—SLC22A1—liver—sarcoma	0.000977	0.00629	CbGeAlD
Procainamide—Rash maculo-papular—Epirubicin—sarcoma	0.00097	0.00525	CcSEcCtD
Procainamide—BCHE—cardiac atrium—sarcoma	0.000969	0.00624	CbGeAlD
Procainamide—Discomfort—Dactinomycin—sarcoma	0.000967	0.00524	CcSEcCtD
Procainamide—BCHE—uterus—sarcoma	0.000964	0.00621	CbGeAlD
Procainamide—Confusional state—Thiotepa—sarcoma	0.000954	0.00516	CcSEcCtD
Procainamide—SLC22A3—liver—sarcoma	0.000934	0.00601	CbGeAlD
Procainamide—Ill-defined disorder—Mitoxantrone—sarcoma	0.000928	0.00503	CcSEcCtD
Procainamide—Thrombocytopenia—Thiotepa—sarcoma	0.000926	0.00501	CcSEcCtD
Procainamide—Thrombocytopenia—Dactinomycin—sarcoma	0.000919	0.00497	CcSEcCtD
Procainamide—Malaise—Mitoxantrone—sarcoma	0.000902	0.00488	CcSEcCtD
Procainamide—Anorexia—Thiotepa—sarcoma	0.000901	0.00488	CcSEcCtD
Procainamide—SCN3A—lymph node—sarcoma	0.000898	0.00579	CbGeAlD
Procainamide—Rash maculo-papular—Doxorubicin—sarcoma	0.000898	0.00486	CcSEcCtD
Procainamide—Anorexia—Dactinomycin—sarcoma	0.000895	0.00484	CcSEcCtD
Procainamide—Convulsion—Vincristine—sarcoma	0.00089	0.00482	CcSEcCtD
Procainamide—Cardiac disorder—Etoposide—sarcoma	0.000887	0.0048	CcSEcCtD
Procainamide—Flushing—Etoposide—sarcoma	0.000887	0.0048	CcSEcCtD
Procainamide—Myalgia—Vincristine—sarcoma	0.000875	0.00474	CcSEcCtD
Procainamide—SLC22A5—tendon—sarcoma	0.000867	0.00559	CbGeAlD
Procainamide—Convulsion—Mitoxantrone—sarcoma	0.000867	0.00469	CcSEcCtD
Procainamide—Hepatic failure—Epirubicin—sarcoma	0.000862	0.00467	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000862	0.00466	CcSEcCtD
Procainamide—Chills—Etoposide—sarcoma	0.000858	0.00464	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000855	0.00463	CcSEcCtD
Procainamide—Arthralgia—Mitoxantrone—sarcoma	0.000852	0.00461	CcSEcCtD
Procainamide—Myalgia—Mitoxantrone—sarcoma	0.000852	0.00461	CcSEcCtD
Procainamide—CYP2D6—hematopoietic system—sarcoma	0.000846	0.00545	CbGeAlD
Procainamide—Discomfort—Mitoxantrone—sarcoma	0.000842	0.00456	CcSEcCtD
Procainamide—Confusional state—Mitoxantrone—sarcoma	0.000823	0.00446	CcSEcCtD
Procainamide—Decreased appetite—Thiotepa—sarcoma	0.000822	0.00445	CcSEcCtD
Procainamide—Thrombocytopenia—Vincristine—sarcoma	0.000821	0.00444	CcSEcCtD
Procainamide—BCHE—bone marrow—sarcoma	0.000818	0.00527	CbGeAlD
Procainamide—Decreased appetite—Dactinomycin—sarcoma	0.000816	0.00442	CcSEcCtD
Procainamide—Dysgeusia—Etoposide—sarcoma	0.000815	0.00441	CcSEcCtD
Procainamide—Renal impairment—Epirubicin—sarcoma	0.000814	0.00441	CcSEcCtD
Procainamide—Shock—Mitoxantrone—sarcoma	0.000803	0.00435	CcSEcCtD
Procainamide—Thrombocytopenia—Mitoxantrone—sarcoma	0.0008	0.00433	CcSEcCtD
Procainamide—Anorexia—Vincristine—sarcoma	0.000799	0.00433	CcSEcCtD
Procainamide—Hepatic failure—Doxorubicin—sarcoma	0.000798	0.00432	CcSEcCtD
Procainamide—Cardiac failure—Epirubicin—sarcoma	0.000794	0.0043	CcSEcCtD
Procainamide—Lethargy—Epirubicin—sarcoma	0.000791	0.00428	CcSEcCtD
Procainamide—SLC22A4—lymph node—sarcoma	0.000787	0.00507	CbGeAlD
Procainamide—Hypotension—Vincristine—sarcoma	0.000784	0.00424	CcSEcCtD
Procainamide—Feeling abnormal—Thiotepa—sarcoma	0.000779	0.00422	CcSEcCtD
Procainamide—Anorexia—Mitoxantrone—sarcoma	0.000778	0.00421	CcSEcCtD
Procainamide—Feeling abnormal—Dactinomycin—sarcoma	0.000773	0.00419	CcSEcCtD
Procainamide—Gastrointestinal pain—Thiotepa—sarcoma	0.000773	0.00419	CcSEcCtD
Procainamide—Ill-defined disorder—Etoposide—sarcoma	0.000772	0.00418	CcSEcCtD
Procainamide—Gastrointestinal pain—Dactinomycin—sarcoma	0.000768	0.00415	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Vincristine—sarcoma	0.000764	0.00414	CcSEcCtD
Procainamide—Hypotension—Mitoxantrone—sarcoma	0.000763	0.00413	CcSEcCtD
Procainamide—Renal impairment—Doxorubicin—sarcoma	0.000753	0.00408	CcSEcCtD
Procainamide—Urticaria—Thiotepa—sarcoma	0.000751	0.00407	CcSEcCtD
Procainamide—Malaise—Etoposide—sarcoma	0.000751	0.00406	CcSEcCtD
Procainamide—Abdominal pain—Thiotepa—sarcoma	0.000748	0.00405	CcSEcCtD
Procainamide—Body temperature increased—Thiotepa—sarcoma	0.000748	0.00405	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000744	0.00403	CcSEcCtD
Procainamide—Abdominal pain—Dactinomycin—sarcoma	0.000742	0.00402	CcSEcCtD
Procainamide—Body temperature increased—Dactinomycin—sarcoma	0.000742	0.00402	CcSEcCtD
Procainamide—Cardiac arrest—Epirubicin—sarcoma	0.000737	0.00399	CcSEcCtD
Procainamide—Cardiac failure—Doxorubicin—sarcoma	0.000735	0.00398	CcSEcCtD
Procainamide—Lethargy—Doxorubicin—sarcoma	0.000732	0.00396	CcSEcCtD
Procainamide—Decreased appetite—Vincristine—sarcoma	0.000729	0.00395	CcSEcCtD
Procainamide—Convulsion—Etoposide—sarcoma	0.000721	0.0039	CcSEcCtD
Procainamide—SLC22A5—testis—sarcoma	0.000718	0.00463	CbGeAlD
Procainamide—SLC22A3—lymph node—sarcoma	0.000716	0.00461	CbGeAlD
Procainamide—Decreased appetite—Mitoxantrone—sarcoma	0.00071	0.00384	CcSEcCtD
Procainamide—Abdominal pain upper—Epirubicin—sarcoma	0.000708	0.00383	CcSEcCtD
Procainamide—Discomfort—Etoposide—sarcoma	0.0007	0.00379	CcSEcCtD
Procainamide—BCHE—testis—sarcoma	0.000699	0.00451	CbGeAlD
Procainamide—Hypersensitivity—Thiotepa—sarcoma	0.000697	0.00377	CcSEcCtD
Procainamide—Hypersensitivity—Dactinomycin—sarcoma	0.000692	0.00374	CcSEcCtD
Procainamide—Gastrointestinal pain—Vincristine—sarcoma	0.000686	0.00371	CcSEcCtD
Procainamide—Confusional state—Etoposide—sarcoma	0.000685	0.00371	CcSEcCtD
Procainamide—Cardiac arrest—Doxorubicin—sarcoma	0.000682	0.00369	CcSEcCtD
Procainamide—SLC22A5—liver—sarcoma	0.000679	0.00437	CbGeAlD
Procainamide—Asthenia—Thiotepa—sarcoma	0.000679	0.00367	CcSEcCtD
Procainamide—Asthenia—Dactinomycin—sarcoma	0.000673	0.00365	CcSEcCtD
Procainamide—Feeling abnormal—Mitoxantrone—sarcoma	0.000673	0.00364	CcSEcCtD
Procainamide—Pruritus—Thiotepa—sarcoma	0.000669	0.00362	CcSEcCtD
Procainamide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000668	0.00361	CcSEcCtD
Procainamide—Thrombocytopenia—Etoposide—sarcoma	0.000665	0.0036	CcSEcCtD
Procainamide—Eosinophilia—Epirubicin—sarcoma	0.000663	0.00359	CcSEcCtD
Procainamide—Abdominal pain—Vincristine—sarcoma	0.000663	0.00359	CcSEcCtD
Procainamide—Body temperature increased—Vincristine—sarcoma	0.000663	0.00359	CcSEcCtD
Procainamide—BCHE—liver—sarcoma	0.000661	0.00426	CbGeAlD
Procainamide—Abdominal pain upper—Doxorubicin—sarcoma	0.000655	0.00354	CcSEcCtD
Procainamide—Urticaria—Mitoxantrone—sarcoma	0.000649	0.00351	CcSEcCtD
Procainamide—Anorexia—Etoposide—sarcoma	0.000648	0.00351	CcSEcCtD
Procainamide—Diarrhoea—Thiotepa—sarcoma	0.000647	0.0035	CcSEcCtD
Procainamide—Abdominal pain—Mitoxantrone—sarcoma	0.000646	0.00349	CcSEcCtD
Procainamide—Body temperature increased—Mitoxantrone—sarcoma	0.000646	0.00349	CcSEcCtD
Procainamide—Diarrhoea—Dactinomycin—sarcoma	0.000642	0.00348	CcSEcCtD
Procainamide—Hypotension—Etoposide—sarcoma	0.000635	0.00344	CcSEcCtD
Procainamide—Neutropenia—Epirubicin—sarcoma	0.000626	0.00339	CcSEcCtD
Procainamide—Dizziness—Thiotepa—sarcoma	0.000625	0.00339	CcSEcCtD
Procainamide—Hypersensitivity—Vincristine—sarcoma	0.000618	0.00334	CcSEcCtD
Procainamide—Eosinophilia—Doxorubicin—sarcoma	0.000613	0.00332	CcSEcCtD
Procainamide—Hypersensitivity—Mitoxantrone—sarcoma	0.000602	0.00326	CcSEcCtD
Procainamide—Asthenia—Vincristine—sarcoma	0.000602	0.00326	CcSEcCtD
Procainamide—Vomiting—Thiotepa—sarcoma	0.000601	0.00325	CcSEcCtD
Procainamide—Vomiting—Dactinomycin—sarcoma	0.000597	0.00323	CcSEcCtD
Procainamide—Decreased appetite—Etoposide—sarcoma	0.000591	0.0032	CcSEcCtD
Procainamide—Renal failure—Epirubicin—sarcoma	0.000587	0.00318	CcSEcCtD
Procainamide—Asthenia—Mitoxantrone—sarcoma	0.000586	0.00317	CcSEcCtD
Procainamide—Neutropenia—Doxorubicin—sarcoma	0.000579	0.00314	CcSEcCtD
Procainamide—Diarrhoea—Vincristine—sarcoma	0.000574	0.00311	CcSEcCtD
Procainamide—Nausea—Thiotepa—sarcoma	0.000562	0.00304	CcSEcCtD
Procainamide—Feeling abnormal—Etoposide—sarcoma	0.00056	0.00303	CcSEcCtD
Procainamide—Diarrhoea—Mitoxantrone—sarcoma	0.000559	0.00302	CcSEcCtD
Procainamide—Nausea—Dactinomycin—sarcoma	0.000558	0.00302	CcSEcCtD
Procainamide—Agranulocytosis—Epirubicin—sarcoma	0.000557	0.00302	CcSEcCtD
Procainamide—Gastrointestinal pain—Etoposide—sarcoma	0.000555	0.00301	CcSEcCtD
Procainamide—Dizziness—Vincristine—sarcoma	0.000555	0.003	CcSEcCtD
Procainamide—Bradycardia—Epirubicin—sarcoma	0.000546	0.00295	CcSEcCtD
Procainamide—Renal failure—Doxorubicin—sarcoma	0.000543	0.00294	CcSEcCtD
Procainamide—Urticaria—Etoposide—sarcoma	0.00054	0.00292	CcSEcCtD
Procainamide—Body temperature increased—Etoposide—sarcoma	0.000537	0.00291	CcSEcCtD
Procainamide—Abdominal pain—Etoposide—sarcoma	0.000537	0.00291	CcSEcCtD
Procainamide—Vomiting—Vincristine—sarcoma	0.000533	0.00289	CcSEcCtD
Procainamide—SLC22A5—lymph node—sarcoma	0.000521	0.00335	CbGeAlD
Procainamide—Vomiting—Mitoxantrone—sarcoma	0.000519	0.00281	CcSEcCtD
Procainamide—Agranulocytosis—Doxorubicin—sarcoma	0.000516	0.00279	CcSEcCtD
Procainamide—BCHE—lymph node—sarcoma	0.000507	0.00327	CbGeAlD
Procainamide—Bradycardia—Doxorubicin—sarcoma	0.000505	0.00273	CcSEcCtD
Procainamide—Hypersensitivity—Etoposide—sarcoma	0.0005	0.00271	CcSEcCtD
Procainamide—Nausea—Vincristine—sarcoma	0.000498	0.0027	CcSEcCtD
Procainamide—Flushing—Epirubicin—sarcoma	0.000497	0.00269	CcSEcCtD
Procainamide—Cardiac disorder—Epirubicin—sarcoma	0.000497	0.00269	CcSEcCtD
Procainamide—Asthenia—Etoposide—sarcoma	0.000487	0.00264	CcSEcCtD
Procainamide—Nausea—Mitoxantrone—sarcoma	0.000485	0.00263	CcSEcCtD
Procainamide—Chills—Epirubicin—sarcoma	0.000481	0.0026	CcSEcCtD
Procainamide—Pruritus—Etoposide—sarcoma	0.000481	0.0026	CcSEcCtD
Procainamide—Diarrhoea—Etoposide—sarcoma	0.000465	0.00252	CcSEcCtD
Procainamide—CYP2D6—testis—sarcoma	0.000463	0.00298	CbGeAlD
Procainamide—Flushing—Doxorubicin—sarcoma	0.00046	0.00249	CcSEcCtD
Procainamide—Cardiac disorder—Doxorubicin—sarcoma	0.00046	0.00249	CcSEcCtD
Procainamide—Dysgeusia—Epirubicin—sarcoma	0.000457	0.00247	CcSEcCtD
Procainamide—Dizziness—Etoposide—sarcoma	0.000449	0.00243	CcSEcCtD
Procainamide—Chills—Doxorubicin—sarcoma	0.000445	0.00241	CcSEcCtD
Procainamide—CYP2D6—liver—sarcoma	0.000438	0.00282	CbGeAlD
Procainamide—Ill-defined disorder—Epirubicin—sarcoma	0.000433	0.00234	CcSEcCtD
Procainamide—Vomiting—Etoposide—sarcoma	0.000432	0.00234	CcSEcCtD
Procainamide—Dysgeusia—Doxorubicin—sarcoma	0.000423	0.00229	CcSEcCtD
Procainamide—Malaise—Epirubicin—sarcoma	0.000421	0.00228	CcSEcCtD
Procainamide—Convulsion—Epirubicin—sarcoma	0.000404	0.00219	CcSEcCtD
Procainamide—Nausea—Etoposide—sarcoma	0.000404	0.00218	CcSEcCtD
Procainamide—Ill-defined disorder—Doxorubicin—sarcoma	0.000401	0.00217	CcSEcCtD
Procainamide—Arthralgia—Epirubicin—sarcoma	0.000397	0.00215	CcSEcCtD
Procainamide—Myalgia—Epirubicin—sarcoma	0.000397	0.00215	CcSEcCtD
Procainamide—Discomfort—Epirubicin—sarcoma	0.000392	0.00212	CcSEcCtD
Procainamide—Malaise—Doxorubicin—sarcoma	0.000389	0.00211	CcSEcCtD
Procainamide—Confusional state—Epirubicin—sarcoma	0.000384	0.00208	CcSEcCtD
Procainamide—Shock—Epirubicin—sarcoma	0.000375	0.00203	CcSEcCtD
Procainamide—Convulsion—Doxorubicin—sarcoma	0.000374	0.00202	CcSEcCtD
Procainamide—Thrombocytopenia—Epirubicin—sarcoma	0.000373	0.00202	CcSEcCtD
Procainamide—Arthralgia—Doxorubicin—sarcoma	0.000368	0.00199	CcSEcCtD
Procainamide—Myalgia—Doxorubicin—sarcoma	0.000368	0.00199	CcSEcCtD
Procainamide—Discomfort—Doxorubicin—sarcoma	0.000363	0.00197	CcSEcCtD
Procainamide—Anorexia—Epirubicin—sarcoma	0.000363	0.00196	CcSEcCtD
Procainamide—Hypotension—Epirubicin—sarcoma	0.000356	0.00193	CcSEcCtD
Procainamide—Confusional state—Doxorubicin—sarcoma	0.000355	0.00192	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000347	0.00188	CcSEcCtD
Procainamide—Shock—Doxorubicin—sarcoma	0.000347	0.00188	CcSEcCtD
Procainamide—Thrombocytopenia—Doxorubicin—sarcoma	0.000345	0.00187	CcSEcCtD
Procainamide—Anorexia—Doxorubicin—sarcoma	0.000336	0.00182	CcSEcCtD
Procainamide—Decreased appetite—Epirubicin—sarcoma	0.000331	0.00179	CcSEcCtD
Procainamide—Hypotension—Doxorubicin—sarcoma	0.000329	0.00178	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000321	0.00174	CcSEcCtD
Procainamide—Feeling abnormal—Epirubicin—sarcoma	0.000314	0.0017	CcSEcCtD
Procainamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000311	0.00169	CcSEcCtD
Procainamide—Decreased appetite—Doxorubicin—sarcoma	0.000306	0.00166	CcSEcCtD
Procainamide—Urticaria—Epirubicin—sarcoma	0.000303	0.00164	CcSEcCtD
Procainamide—Body temperature increased—Epirubicin—sarcoma	0.000301	0.00163	CcSEcCtD
Procainamide—Abdominal pain—Epirubicin—sarcoma	0.000301	0.00163	CcSEcCtD
Procainamide—Feeling abnormal—Doxorubicin—sarcoma	0.00029	0.00157	CcSEcCtD
Procainamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000288	0.00156	CcSEcCtD
Procainamide—Hypersensitivity—Epirubicin—sarcoma	0.000281	0.00152	CcSEcCtD
Procainamide—Urticaria—Doxorubicin—sarcoma	0.00028	0.00152	CcSEcCtD
Procainamide—Abdominal pain—Doxorubicin—sarcoma	0.000279	0.00151	CcSEcCtD
Procainamide—Body temperature increased—Doxorubicin—sarcoma	0.000279	0.00151	CcSEcCtD
Procainamide—Asthenia—Epirubicin—sarcoma	0.000273	0.00148	CcSEcCtD
Procainamide—Pruritus—Epirubicin—sarcoma	0.000269	0.00146	CcSEcCtD
Procainamide—Diarrhoea—Epirubicin—sarcoma	0.000261	0.00141	CcSEcCtD
Procainamide—Hypersensitivity—Doxorubicin—sarcoma	0.00026	0.00141	CcSEcCtD
Procainamide—Asthenia—Doxorubicin—sarcoma	0.000253	0.00137	CcSEcCtD
Procainamide—Dizziness—Epirubicin—sarcoma	0.000252	0.00136	CcSEcCtD
Procainamide—Pruritus—Doxorubicin—sarcoma	0.000249	0.00135	CcSEcCtD
Procainamide—Vomiting—Epirubicin—sarcoma	0.000242	0.00131	CcSEcCtD
Procainamide—Diarrhoea—Doxorubicin—sarcoma	0.000241	0.0013	CcSEcCtD
Procainamide—Dizziness—Doxorubicin—sarcoma	0.000233	0.00126	CcSEcCtD
Procainamide—Nausea—Epirubicin—sarcoma	0.000226	0.00122	CcSEcCtD
Procainamide—Vomiting—Doxorubicin—sarcoma	0.000224	0.00121	CcSEcCtD
Procainamide—SCN3A—Developmental Biology—KDR—sarcoma	0.000213	0.00133	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—VEGFA—sarcoma	0.000213	0.00133	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCR4—sarcoma	0.000212	0.00132	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CTNNB1—sarcoma	0.000211	0.00132	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—NRAS—sarcoma	0.00021	0.00131	CbGpPWpGaD
Procainamide—Nausea—Doxorubicin—sarcoma	0.000209	0.00113	CcSEcCtD
Procainamide—SCN11A—Axon guidance—EGFR—sarcoma	0.000209	0.0013	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—KDR—sarcoma	0.000205	0.00128	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—KDR—sarcoma	0.000205	0.00128	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—KRAS—sarcoma	0.000198	0.00123	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000197	0.00123	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—KDR—sarcoma	0.000197	0.00123	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—KDR—sarcoma	0.000197	0.00123	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR4—sarcoma	0.000197	0.00123	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CREB1—sarcoma	0.000195	0.00122	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—KDR—sarcoma	0.000194	0.00121	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000192	0.0012	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—EGFR—sarcoma	0.000191	0.00119	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—SRC—sarcoma	0.000191	0.00119	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—CREB1—sarcoma	0.00019	0.00119	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—HRAS—sarcoma	0.000188	0.00117	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CTNNB1—sarcoma	0.000188	0.00117	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CREB1—sarcoma	0.000187	0.00116	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—VEGFA—sarcoma	0.000186	0.00116	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—NRAS—sarcoma	0.000184	0.00115	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP2—sarcoma	0.000182	0.00113	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—KRAS—sarcoma	0.000181	0.00113	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CREB1—sarcoma	0.000179	0.00112	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CREB1—sarcoma	0.000179	0.00112	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—SRC—sarcoma	0.000176	0.0011	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP2—sarcoma	0.000174	0.00108	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CREB1—sarcoma	0.000173	0.00108	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CREB1—sarcoma	0.000173	0.00108	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CTNNB1—sarcoma	0.000172	0.00107	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—VEGFA—sarcoma	0.000172	0.00107	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—CREB1—sarcoma	0.00017	0.00106	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—SRC—sarcoma	0.00017	0.00106	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—CREB1—sarcoma	0.00017	0.00106	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—NRAS—sarcoma	0.00017	0.00106	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—SRC—sarcoma	0.000169	0.00105	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000169	0.00105	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—HRAS—sarcoma	0.000168	0.00105	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000168	0.00105	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EGFR—sarcoma	0.000167	0.00104	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP2—sarcoma	0.000167	0.00104	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP2—sarcoma	0.000167	0.00104	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VEGFA—sarcoma	0.000166	0.00103	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—sarcoma	0.000164	0.00103	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—NRAS—sarcoma	0.000164	0.00102	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000163	0.00102	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—NRAS—sarcoma	0.000162	0.00101	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—SRC—sarcoma	0.000162	0.00101	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—SRC—sarcoma	0.000162	0.00101	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP2—sarcoma	0.000161	0.001	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP2—sarcoma	0.000161	0.001	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP2—sarcoma	0.000159	0.000989	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—KRAS—sarcoma	0.000158	0.000986	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—sarcoma	0.000158	0.000985	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—sarcoma	0.000158	0.000985	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000158	0.000984	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—MDM2—sarcoma	0.000157	0.000982	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—SRC—sarcoma	0.000156	0.000975	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—SRC—sarcoma	0.000156	0.000975	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—NRAS—sarcoma	0.000156	0.000973	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—NRAS—sarcoma	0.000156	0.000973	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—SRC—sarcoma	0.000156	0.000971	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—sarcoma	0.000155	0.000964	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—HRAS—sarcoma	0.000154	0.000958	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—sarcoma	0.000152	0.00095	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—sarcoma	0.000152	0.00095	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—sarcoma	0.000152	0.000946	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—CREB1—sarcoma	0.000152	0.000946	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—NRAS—sarcoma	0.00015	0.000938	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—NRAS—sarcoma	0.00015	0.000938	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—NRAS—sarcoma	0.00015	0.000934	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—sarcoma	0.000149	0.00093	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—sarcoma	0.000148	0.000923	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—KRAS—sarcoma	0.000146	0.000911	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—CREB1—sarcoma	0.000146	0.000909	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000142	0.000887	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—sarcoma	0.000142	0.000886	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—sarcoma	0.000142	0.000886	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000142	0.000886	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—CREB1—sarcoma	0.000141	0.000881	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—KRAS—sarcoma	0.000141	0.000879	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000141	0.000879	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—MDM2—sarcoma	0.00014	0.000876	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—KRAS—sarcoma	0.00014	0.000871	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CTNNB1—sarcoma	0.000139	0.000869	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KDR—sarcoma	0.000139	0.000865	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—sarcoma	0.000137	0.000855	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—sarcoma	0.000137	0.000855	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—sarcoma	0.000136	0.000851	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—sarcoma	0.000134	0.000838	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—KRAS—sarcoma	0.000134	0.000837	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—KRAS—sarcoma	0.000134	0.000837	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.000133	0.000831	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—CREB1—sarcoma	0.00013	0.000811	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—KRAS—sarcoma	0.000129	0.000807	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—KRAS—sarcoma	0.000129	0.000807	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—KRAS—sarcoma	0.000129	0.000804	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCR4—sarcoma	0.000128	0.000801	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000128	0.000798	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CTNNB1—sarcoma	0.000128	0.000798	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000127	0.000794	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—SRC—sarcoma	0.000126	0.000785	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—MDM2—sarcoma	0.000125	0.000782	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—sarcoma	0.000124	0.000774	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000124	0.000774	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000123	0.00077	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CTNNB1—sarcoma	0.000123	0.00077	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—sarcoma	0.000123	0.000765	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CREB1—sarcoma	0.000122	0.000758	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—NRAS—sarcoma	0.000121	0.000755	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—MDM2—sarcoma	0.000121	0.000752	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—SRC—sarcoma	0.00012	0.000751	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—sarcoma	0.00012	0.000747	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—sarcoma	0.000119	0.000741	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—sarcoma	0.000117	0.000732	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—MDM2—sarcoma	0.000117	0.000729	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—CREB1—sarcoma	0.000116	0.000725	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—NRAS—sarcoma	0.000116	0.000723	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—SRC—sarcoma	0.000116	0.000722	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—SRC—sarcoma	0.000116	0.000722	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000114	0.000712	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—sarcoma	0.000114	0.000712	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—sarcoma	0.000114	0.000712	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000113	0.000707	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP2—sarcoma	0.000113	0.000706	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—sarcoma	0.000113	0.000703	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—sarcoma	0.000113	0.000703	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000113	0.000702	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000112	0.000696	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—SRC—sarcoma	0.000112	0.000696	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—SRC—sarcoma	0.000112	0.000696	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—NRAS—sarcoma	0.000111	0.000694	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—NRAS—sarcoma	0.000111	0.000694	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—sarcoma	0.00011	0.000688	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—sarcoma	0.00011	0.000686	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—sarcoma	0.00011	0.000686	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—SRC—sarcoma	0.00011	0.000686	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—sarcoma	0.00011	0.000683	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—sarcoma	0.000109	0.000678	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—sarcoma	0.000109	0.000678	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—CREB1—sarcoma	0.000108	0.000675	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—MDM2—sarcoma	0.000108	0.000671	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—NRAS—sarcoma	0.000107	0.000669	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—NRAS—sarcoma	0.000107	0.000669	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—sarcoma	0.000107	0.000668	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ENO2—sarcoma	0.000107	0.000666	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HBA1—sarcoma	0.000106	0.000662	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—NRAS—sarcoma	0.000106	0.000659	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—sarcoma	0.000106	0.000658	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000105	0.000658	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—KRAS—sarcoma	0.000104	0.00065	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—sarcoma	0.000102	0.000633	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—sarcoma	0.000101	0.000632	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—sarcoma	0.000101	0.000632	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—KRAS—sarcoma	9.97e-05	0.000622	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—sarcoma	9.91e-05	0.000618	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—sarcoma	9.78e-05	0.00061	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—sarcoma	9.78e-05	0.00061	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—sarcoma	9.64e-05	0.000601	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—MDM2—sarcoma	9.61e-05	0.000599	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—KRAS—sarcoma	9.58e-05	0.000597	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—KRAS—sarcoma	9.58e-05	0.000597	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	9.38e-05	0.000585	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—sarcoma	9.25e-05	0.000577	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—KRAS—sarcoma	9.24e-05	0.000576	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—KRAS—sarcoma	9.24e-05	0.000576	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—KRAS—sarcoma	9.1e-05	0.000568	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PLCG1—sarcoma	9.07e-05	0.000565	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—MDM2—sarcoma	8.96e-05	0.000559	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—sarcoma	8.86e-05	0.000553	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—sarcoma	8.74e-05	0.000545	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CTNNB1—sarcoma	8.68e-05	0.000541	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—sarcoma	8.64e-05	0.000539	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—sarcoma	8.48e-05	0.000529	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO2—sarcoma	8.41e-05	0.000524	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HBA1—sarcoma	8.36e-05	0.000521	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—sarcoma	8.15e-05	0.000508	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—sarcoma	8.15e-05	0.000508	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—sarcoma	7.85e-05	0.00049	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—sarcoma	7.85e-05	0.00049	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—SRC—sarcoma	7.85e-05	0.000489	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—sarcoma	7.74e-05	0.000482	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—sarcoma	7.71e-05	0.000481	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—sarcoma	7.64e-05	0.000476	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NRAS—sarcoma	7.55e-05	0.000471	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO2—sarcoma	7.5e-05	0.000468	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HBA1—sarcoma	7.46e-05	0.000465	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCR4—sarcoma	7.26e-05	0.000453	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PLCG1—sarcoma	7.14e-05	0.000445	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—sarcoma	6.89e-05	0.000429	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—sarcoma	6.88e-05	0.000429	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO2—sarcoma	6.7e-05	0.000418	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HBA1—sarcoma	6.66e-05	0.000415	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—sarcoma	6.64e-05	0.000414	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP2—sarcoma	6.63e-05	0.000414	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—sarcoma	6.62e-05	0.000413	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCR4—sarcoma	6.59e-05	0.000411	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KRAS—sarcoma	6.5e-05	0.000405	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—sarcoma	6.42e-05	0.0004	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PLCG1—sarcoma	6.37e-05	0.000397	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO2—sarcoma	6.25e-05	0.000389	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HBA1—sarcoma	6.21e-05	0.000387	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TLE1—sarcoma	6.11e-05	0.000381	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP2—sarcoma	5.92e-05	0.000369	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—sarcoma	5.91e-05	0.000368	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PLCG1—sarcoma	5.69e-05	0.000355	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—sarcoma	5.52e-05	0.000344	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PLCG1—sarcoma	5.3e-05	0.00033	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—sarcoma	5.28e-05	0.000329	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFC—sarcoma	5.16e-05	0.000322	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—sarcoma	5.09e-05	0.000317	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—sarcoma	4.92e-05	0.000307	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—sarcoma	4.54e-05	0.000283	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FLT1—sarcoma	4.12e-05	0.000257	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PLCG1—sarcoma	4.05e-05	0.000253	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR4—sarcoma	3.89e-05	0.000243	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ATF1—sarcoma	3.85e-05	0.00024	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CREB1—sarcoma	3.53e-05	0.00022	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO2—sarcoma	3.45e-05	0.000215	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HBA1—sarcoma	3.43e-05	0.000214	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1R—sarcoma	3.02e-05	0.000188	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PLCG1—sarcoma	2.93e-05	0.000183	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FOXO1—sarcoma	2.88e-05	0.000179	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—sarcoma	2.87e-05	0.000179	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDGFRB—sarcoma	2.87e-05	0.000179	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDGFRA—sarcoma	2.83e-05	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—sarcoma	2.61e-05	0.000163	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KDR—sarcoma	2.38e-05	0.000148	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KIT—sarcoma	2.19e-05	0.000137	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NRAS—sarcoma	2.19e-05	0.000137	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CREB1—sarcoma	2.09e-05	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—sarcoma	2e-05	0.000125	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KRAS—sarcoma	1.89e-05	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MDM2—sarcoma	1.73e-05	0.000108	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—sarcoma	1.6e-05	0.0001	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—sarcoma	1.54e-05	9.62e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—sarcoma	1.5e-05	9.37e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUN—sarcoma	1.5e-05	9.35e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—sarcoma	1.49e-05	9.28e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SRC—sarcoma	1.35e-05	8.39e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—sarcoma	1.31e-05	8.17e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRAS—sarcoma	1.29e-05	8.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—sarcoma	1.21e-05	7.52e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—sarcoma	1.18e-05	7.35e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KRAS—sarcoma	1.11e-05	6.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—sarcoma	9.9e-06	6.18e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—sarcoma	9.47e-06	5.91e-05	CbGpPWpGaD
